• Mercy Foundation
    $50,000 through May, 2021

    to support the Sacramento MS Center to provide remote medical services during COVID-19.

    Multiple Sclerosis USA Awarded: April, 2020
  • Washington University
    $106,000 through December, 2021

    to support Dr. Anne Cross' research on gradient echo MRI techniques to detect and measure the evolution of progressive Multiple Sclerosis.

    Multiple Sclerosis USA Awarded: October, 2019
  • University of British Columbia Division of Neurology
    $240,000 through August, 2021

    to improve and standardize MS imaging for clinical and research purposes.

    Multiple Sclerosis International Awarded: July, 2019
  • Archdiocese of Los Angeles
    $2,700,000 through June, 2022

    To support Phase II of the expansion of dual-language immersion schools and launch the STEM network in the Archdiocese of Los Angeles.

    Multiple Sclerosis USA Awarded: May, 2019
  • Mercy Foundation
    $600,000 through July, 2022

    to support the MS Achievement Center serving Sacramento and the Northern California region.

    Multiple Sclerosis USA Awarded: May, 2019
  • Regents University of California Los Angeles
    $1,600,000 through May, 2022

    To support Dr. Rhonda Voskuhl's research on disability-specific disease modifying treatments in multiple sclerosis.

    Multiple Sclerosis USA Awarded: May, 2019
  • American Brain Foundation
    $65,000 through May, 2018

    to support the launch of a new crowdfunding platform for campaigns focused on research in Multiple Sclerosis during MS Awareness Month.

    Multiple Sclerosis USA Awarded: March, 2018
  • Regents University of California Los Angeles
    $185,000 through October, 2019

    to support planning for a phase III clinical trial of estriol.

    Multiple Sclerosis USA Awarded: November, 2017
  • J. David Gladstone Institutes
    $405,000 through October, 2019

    to support research on the coagulation cascade as a biomarker for progressive multiple sclerosis.

    Multiple Sclerosis USA Awarded: November, 2017
  • National Institutes of Health
    $74,062 through June, 2019

    to identify new biomarkers of inflammation and neurodegeneration using the plasma of patients with MS.

    Multiple Sclerosis USA Awarded: October, 2017